SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this research is to study the safety and effectiveness of bilateral stimulation of the anterior nucleus of the thalamus as adjunctive therapy for reducing the frequency of seizures in adults diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are refractory to antiepileptic medications.

Official Title

SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Exclusion Criteria:
  1. - Multilobar (>3 different lobes) anatomic areas of seizure onset - Symptomatic generalized epilepsy - Previous diagnosis of psychogenic/non-epileptic seizures - Presence of implanted electrical stimulation medical device anywhere in the body (e.g., cardiac pacemakers, spinal cord stimulator) or any metallic implants in the head (e.g., aneurysm clip, cochlear implant). Vagal nerve stimulators are allowed if the device has been turned off for at least 30 days prior to the Baseline Week -12 visit and the patient agrees to have the generator explanted prior to or at the time of the Kinetra Neurostimulator implant.


Robert Fisher, MD, PhD
Robert Fisher, MD, PhD
Epilepsy specialist, Neurophysiologist, Neurologist
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.


Mimi Callanan, NP